Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 16 | 2025 | 1039 | 3.440 |
Why?
|
| Genome-Wide Association Study | 10 | 2025 | 1763 | 2.040 |
Why?
|
| Genetic Predisposition to Disease | 10 | 2025 | 2466 | 1.300 |
Why?
|
| Hypersensitivity | 1 | 2024 | 162 | 0.770 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2022 | 54 | 0.750 |
Why?
|
| HLA Antigens | 2 | 2019 | 228 | 0.680 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2019 | 10 | 0.610 |
Why?
|
| Bronchial Thermoplasty | 1 | 2019 | 6 | 0.610 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2019 | 93 | 0.560 |
Why?
|
| Immunologic Memory | 1 | 2019 | 184 | 0.560 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2019 | 288 | 0.530 |
Why?
|
| Lung | 3 | 2021 | 1365 | 0.510 |
Why?
|
| Biological Products | 1 | 2019 | 178 | 0.510 |
Why?
|
| Lymph Nodes | 1 | 2019 | 548 | 0.470 |
Why?
|
| Precision Medicine | 1 | 2019 | 456 | 0.440 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 1115 | 0.440 |
Why?
|
| Genotype | 1 | 2019 | 1866 | 0.440 |
Why?
|
| Phenotype | 6 | 2024 | 2545 | 0.360 |
Why?
|
| Genes, Immunoglobulin | 1 | 2012 | 61 | 0.360 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2012 | 67 | 0.360 |
Why?
|
| Multifactorial Inheritance | 2 | 2024 | 202 | 0.360 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2012 | 103 | 0.340 |
Why?
|
| Age of Onset | 3 | 2025 | 342 | 0.330 |
Why?
|
| Genetic Loci | 3 | 2022 | 260 | 0.330 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2009 | 183 | 0.320 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2009 | 291 | 0.310 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2012 | 236 | 0.300 |
Why?
|
| Inflammation Mediators | 1 | 2009 | 159 | 0.280 |
Why?
|
| Humans | 22 | 2025 | 93613 | 0.260 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2025 | 2484 | 0.230 |
Why?
|
| Allergens | 2 | 2024 | 189 | 0.220 |
Why?
|
| Respiratory Sounds | 1 | 2025 | 39 | 0.220 |
Why?
|
| Spirometry | 1 | 2025 | 77 | 0.220 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 1919 | 0.200 |
Why?
|
| Immunoglobulin E | 1 | 2024 | 148 | 0.200 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2025 | 293 | 0.190 |
Why?
|
| Risk Factors | 3 | 2023 | 5914 | 0.180 |
Why?
|
| Interleukin-33 | 1 | 2021 | 28 | 0.170 |
Why?
|
| Transcriptome | 2 | 2025 | 761 | 0.170 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2021 | 7 | 0.170 |
Why?
|
| Respiratory Mucosa | 1 | 2021 | 90 | 0.160 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2021 | 109 | 0.160 |
Why?
|
| Child | 7 | 2025 | 7362 | 0.150 |
Why?
|
| V(D)J Recombination | 1 | 2019 | 12 | 0.150 |
Why?
|
| Gene Ontology | 1 | 2019 | 37 | 0.150 |
Why?
|
| Cellular Reprogramming | 1 | 2019 | 50 | 0.150 |
Why?
|
| Case-Control Studies | 4 | 2021 | 1932 | 0.150 |
Why?
|
| Neoplasm Proteins | 1 | 2022 | 538 | 0.150 |
Why?
|
| Immunophenotyping | 1 | 2019 | 224 | 0.150 |
Why?
|
| Genomics | 1 | 2025 | 848 | 0.150 |
Why?
|
| Influenza, Human | 1 | 2021 | 347 | 0.130 |
Why?
|
| Rhinitis, Allergic | 1 | 2018 | 52 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2018 | 109 | 0.130 |
Why?
|
| Periodicals as Topic | 1 | 2019 | 168 | 0.130 |
Why?
|
| Neovascularization, Pathologic | 2 | 2009 | 353 | 0.130 |
Why?
|
| Environmental Exposure | 1 | 2019 | 355 | 0.120 |
Why?
|
| Pandemics | 1 | 2021 | 875 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1517 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 2718 | 0.100 |
Why?
|
| Child, Preschool | 3 | 2025 | 3833 | 0.100 |
Why?
|
| Genome, Human | 1 | 2018 | 823 | 0.100 |
Why?
|
| Biomarkers | 1 | 2019 | 1913 | 0.100 |
Why?
|
| Autopsy | 2 | 2021 | 126 | 0.080 |
Why?
|
| Animals | 6 | 2024 | 28047 | 0.080 |
Why?
|
| Epoxy Compounds | 1 | 2009 | 10 | 0.070 |
Why?
|
| Valine | 1 | 2009 | 46 | 0.070 |
Why?
|
| Arthritis, Experimental | 1 | 2009 | 26 | 0.070 |
Why?
|
| Base Sequence | 1 | 2012 | 2209 | 0.070 |
Why?
|
| Gene Expression | 1 | 2012 | 1304 | 0.070 |
Why?
|
| Quantitative Trait Loci | 2 | 2025 | 630 | 0.070 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 2889 | 0.070 |
Why?
|
| Male | 7 | 2025 | 44582 | 0.070 |
Why?
|
| Female | 8 | 2025 | 48781 | 0.070 |
Why?
|
| Oxazines | 1 | 2007 | 15 | 0.070 |
Why?
|
| B-Lymphocytes | 1 | 2012 | 703 | 0.070 |
Why?
|
| Bone Resorption | 1 | 2007 | 43 | 0.060 |
Why?
|
| Prodrugs | 1 | 2007 | 51 | 0.060 |
Why?
|
| Chromatin | 2 | 2021 | 440 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2009 | 962 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2007 | 302 | 0.060 |
Why?
|
| Pyridines | 1 | 2007 | 302 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2007 | 392 | 0.060 |
Why?
|
| Vital Capacity | 1 | 2025 | 73 | 0.050 |
Why?
|
| Forced Expiratory Volume | 1 | 2025 | 136 | 0.050 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2024 | 64 | 0.050 |
Why?
|
| Coenzyme A | 1 | 2022 | 13 | 0.050 |
Why?
|
| Adult | 4 | 2025 | 27949 | 0.050 |
Why?
|
| Japan | 1 | 2022 | 299 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2025 | 1052 | 0.040 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2021 | 20 | 0.040 |
Why?
|
| Adolescent | 2 | 2025 | 9612 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 1166 | 0.040 |
Why?
|
| Amino Acids | 1 | 2022 | 246 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 208 | 0.040 |
Why?
|
| Inflammation | 1 | 2007 | 1050 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2021 | 303 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2022 | 402 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2025 | 581 | 0.040 |
Why?
|
| Seasons | 1 | 2021 | 240 | 0.040 |
Why?
|
| Zebrafish | 1 | 2021 | 339 | 0.040 |
Why?
|
| Comorbidity | 1 | 2022 | 1007 | 0.040 |
Why?
|
| Mass Screening | 1 | 2024 | 708 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2021 | 959 | 0.030 |
Why?
|
| Collagen Type II | 2 | 2009 | 16 | 0.030 |
Why?
|
| Alleles | 1 | 2021 | 1139 | 0.030 |
Why?
|
| Mice | 1 | 2012 | 12239 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 1584 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2021 | 1790 | 0.030 |
Why?
|
| Risk | 1 | 2018 | 657 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2018 | 697 | 0.020 |
Why?
|
| Aged | 2 | 2021 | 20472 | 0.020 |
Why?
|
| United States | 1 | 2025 | 7642 | 0.020 |
Why?
|
| Rats | 2 | 2009 | 4042 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2018 | 1415 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 2009 | 303 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2009 | 212 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2009 | 131 | 0.020 |
Why?
|
| Biological Availability | 1 | 2009 | 86 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2009 | 306 | 0.020 |
Why?
|
| Arthus Reaction | 1 | 2007 | 1 | 0.020 |
Why?
|
| Syk Kinase | 1 | 2007 | 8 | 0.020 |
Why?
|
| Synovial Fluid | 1 | 2007 | 11 | 0.020 |
Why?
|
| Synovitis | 1 | 2007 | 14 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2009 | 657 | 0.020 |
Why?
|
| Morpholines | 1 | 2007 | 61 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2009 | 712 | 0.020 |
Why?
|
| Receptors, IgG | 1 | 2007 | 68 | 0.020 |
Why?
|
| Aminopyridines | 1 | 2007 | 48 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2007 | 465 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2007 | 384 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 1243 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 2493 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 27623 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2007 | 3500 | 0.010 |
Why?
|